// App-Quantinova.ai

: Study of Venetoclax Plasma Concentrations during Co-Administration with Posaconazole in Acute Myeloid Leukemia (AML) Patients

Researchers

Presenter

  • Patrizia Zappasodi

Principal Investigators

  • Simona De Gregori

  • Eleonora Gelli

  • Elisa Roncoroni

  • Marianna Rossi

  • Claudia Patricia Tobar Cabrera

  • Eugenio Santacroce

  • Gianluca Martini

  • Ludovica Calabretta

  • Riccardo Albertini

  • Luca Arcaini

Medical Centers

  • Department of Diagnostic Medicine, Clinical and Experimental Pharmacokinetics Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Department of Hematology Oncology, Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Department of Molecular Medicine, University of Pavia, Pavia, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic myelomonocytic leukemia

  • Myeloid neoplasms

  • Acute myelocytic leukemia

  • Myelodysplastic Syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Posaconazole

  • Vidaza

  • Decitabine

  • Venetoclax

Outcome

  • N/A

Study Design

  • Dose Escalation

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved